Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Lymphoma patients needed for trial
Six months of free remission monitoring to aid study

Axiom Veterinary Laboratories are looking for dogs that have been diagnosed with lymphoma in order to validate a test.

The test has been developed by Petscreen, to find acute phase proteins for monitoring remission in canine lymphoma patients.

Axiom will be performing a trial of Petscreen's work, to assess its ability to detect when a lymphoma patient is in and out of remission. If validated, vets old be provided with a method of identifying relapse earlier than palpation alone, which could potentially extend patient's lives.

To be involved in the trial, Axiom are looking for dogs that have cytologically or histologically confirmed lymphoma, diagnosed within two weeks of the first serum sample being taken. Preferably, they would not have received any treatment, including steroids.

The process will involve testing a serum sample taken from the patient at week zero, followed by monthly tests to monitor the patient's status, therefore, offering 100 patients six months of free remission monitoring.

If you would like a discussion, or have any patients you would like to put forward for the trial, please contact Emma Dewhurst of Axiom on 01626 355655 or via email.

Click here to find out more about Petscreen's work on the development so far.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.